S&P 500 Futures
(0.09%) 5 332.00 points

Dow Jones Futures
(0.02%) 40 145 points

Nasdaq Futures
(0.14%) 18 661 points

Oil
(-0.32%) $79.80

Gas
(0.53%) $2.64

Gold
(1.31%) $2 449.00

Silver
(3.03%) $32.21

Platinum
(0.32%) $1 093.50

USD/EUR
(0.04%) $0.920

USD/NOK
(0.01%) $10.68

USD/GBP
(0.03%) $0.787

USD/RUB
(-0.33%) $90.67

Realtime updates for Odonate Therapeutics, [ODTC]

Exchange: OTC Sector: Healthcare Industry: Biotechnology

Last Updated7 May 2024 @ 15:56

25% discount on Stockinvest.us - Use code: Podcast

-83.34% $ 2 849.50

Live Chart Being Loaded With Signals

Commentary (7 May 2024 @ 15:56):

Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer...

Stats
Today's Volume	2.00
Average Volume	19.00
Market Cap	10.97M
EPS	$0 ( 2022-11-07 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0900
ATR14	$909.48 (31.92%)

Volume Correlation

Long: 0.33 (neutral)

Short: 0.00 (neutral)

Signal:(20.001) Neutral

Odonate Therapeutics, Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Odonate Therapeutics, Correlation - Currency/Commodity

-0.37
( neutral )

0.21
( neutral )

-0.28
( neutral )

0.32
( neutral )

0.38
( neutral )

0.49
( neutral )

Odonate Therapeutics, Financials

Annual	2023
Revenue:	$0
Gross Profit:	$-21 000.00 (0.00 %)
EPS:	$2.56

FY	2023
Revenue:	$0
Gross Profit:	$-21 000.00 (0.00 %)
EPS:	$2.56

FY	2020
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-3.84

FY	2019
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-4.05

Financial Reports:

No articles found.

Odonate Therapeutics, Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Odonate Therapeutics,

Odonate Therapeutics, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was founded in 2013 and is based in New York, New York.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Investing in the stock market involves risk and the value of your investment can fluctuate. The stock market can be affected by a variety of factors, including economic conditions, company performance, and global events. There is no guarantee of profit and you could lose money. Please consider your financial situation, investment goals, and level of risk tolerance before making any investment decisions. Consult with a financial advisor for personalized advice.